Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical data-Reference-Cited by-同舟云学术

Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical data

Published:2004-04 Issue:4 Volume:147 Page:564-572
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Black Henry R

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference80 articles.

1. Heart and stroke facts: 2002 statistical supplement. Dallas, Tex: American Heart Association; 2001

2. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure;Arch Intern Med,1997

3. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension;Blood Press,1999

4. Reflections on hypertension control rates;Lenfant;Arch Intern Med,2002

5. Residual lifetime risk for developing hypertension in middle-aged women and men;Vasan;JAMA,2002

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidative Stress and Heart Failure;Reference Module in Biomedical Sciences;2024

2. Physiology of the normal heart;Surgery (Oxford);2018-02

3. Physiology of the normal heart;Surgery (Oxford);2015-02

4. Physiology of the normal heart;Medicine;2014-08

5. Spironolactone; the ultimate blocker of RAAS cascade in hypertensive patients with special reference to its cardiovascular benefits: Revisiting the forgotten ways;Bangladesh Journal of Medical Science;2012-07-24